Holen Sie sich die Stockscreener-App
16.00
8.18%
1.21
Schlusskurs vom Vortag:
$14.79
Offen:
$14.84
24-Stunden-Volumen:
184.22K
Relative Volume:
0.43
Marktkapitalisierung:
$1.06B
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
-3.79%
1M Leistung:
-27.77%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$14.60
$16.89
52-Wochen-Spanne:
$14.60
$25.93
Latigo Biotherapeutics, Inc. Common Stock Stock (LTGO) Company Profile
Firmenname
Latigo Biotherapeutics, Inc. Common Stock
Sektor
Branche
Telefon
-
Adresse
-
Compare LTGO vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LTGO
Latigo Biotherapeutics, Inc. Common Stock
|
16.00 | 1.06B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.89 | 128.98B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
212.54 | 84.85B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
765.84 | 78.85B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
818.91 | 51.50B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
192.94 | 41.36B | 742.00K | -1.37B | -1.07B | -7.0731 |
Latigo Biotherapeutics, Inc. Common Stock Stock (LTGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-01 | Eingeleitet | Goldman | Buy |
| 2026-09-01 | Eingeleitet | Guggenheim | Buy |
| 2026-09-01 | Eingeleitet | Jefferies | Buy |
| 2026-09-01 | Eingeleitet | Leerink Partners | Outperform |
Latigo Biotherapeutics, Inc. Common Stock Aktie (LTGO) Neueste Nachrichten
Latigo Biotherapeutics, Inc. Common Stock (NASDAQ: LTGO) Stock Price, News & Analysis - kalkine.ca
Latigo Biotherapeutics, Inc. Common Stock (LTGO) Earnings Reports & Dates - FXEmpire
Latigo Biotherapeutics Q2 Results: EPS loss narrows 24% YoY - scanx.trade
Latigo Biotherapeutics (LTGO) draws 4.45M-share stake from Deep Track - Stock Titan
Sanofi Converts Series B Preferred Stock and Convertible Note into Latigo Biotherapeutics Common Shares Following IPO - Kalkine Media
Latigo Biotherapeutics Completes IPO and Updates Governance - TipRanks
Latigo Biotherapeutics (LTGO) On IPO And Trial Data Looks About Right Valued - Yahoo Finance
Latigo Biotherapeutics (Nasdaq:LTGO)Stock Analysis - Simply Wall Street
Latigo Biotherapeutics Prices Upsized $345.6 Million Initial Public Offering - quiverquant.com
Latham & Watkins Advises on Latigo Biotherapeutics’ Upsized US$345.6 Million Initial Public Offering - Latham & Watkins LLP
Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering - GlobeNewswire
Latigo Biotherapeutics prices $345.6M IPO at $18 per share - Investing.com
Latigo Biotherapeutics files for Nasdaq IPO at up to $18 per share - Investing.com
Latigo Biotherapeutics files for $256M-$288M Nasdaq IPO - scanx.trade
Latigo Biotherapeutics Commences IPO Process For Pain Treatment Pipeline (Pending:LTGO) - Seeking Alpha
Finanzdaten der Latigo Biotherapeutics, Inc. Common Stock-Aktie (LTGO)
Es liegen keine Finanzdaten für Latigo Biotherapeutics, Inc. Common Stock (LTGO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Latigo Biotherapeutics, Inc. Common Stock-Aktie (LTGO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tananbaum James B. | Director |
Aug 10 '26 |
Buy |
18.00 |
140,000 |
2,520,000 |
2,008,024 |
5.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):